IDR

Advertisement
Oct 21 2025HEALTH

How a Plant Compound Might Help Fight Bone Loss in Older Mice

Researchers have been looking into a substance called salidroside, found in Rhodiola plants, to see if it can help with bone loss in older mice. They already knew it could help with memory issues in these mice, so they wanted to see if it could also help with their bones. They did some tests and fo

reading time less than a minute
Jul 03 2025SCIENCE

Tiny Warriors Against Superbugs: How Phages Can Save The Day

In hospitals, there's a sneaky threat called Enterobacter hormaechei. It's part of a bigger group called the Enterobacter cloacae complex, which is known for causing infections. What makes this germ extra tricky? It can form a sticky layer called biofilm on things like catheters. This biofilm acts l

reading time less than a minute
Jun 28 2025HEALTH

Sweat Less, Live More: Exploring New Treatments for Excessive Sweating

Excessive sweating can be a real bother. It's not just about feeling uncomfortable. It can also mess with your confidence and daily life. You might have heard of treatments like OnabotulinumtoxinA injections. These are often used for sweaty armpits. But what if you sweat in other places? Like your f

reading time less than a minute
Jun 16 2025HEALTH

The Silent Battle Against Superbugs in Kids

The world has been grappling with a growing problem: superbugs. These are bacteria that have become resistant to many types of antibiotics. This issue is especially tough in hospitals, where children are often fighting other health problems. Gram-negative bacteria are a big part of this problem. The

reading time less than a minute
Apr 13 2025HEALTH

ICU's Silent Battle: The Rise of Superbugs During COVID-19

The COVID-19 pandemic has put intensive care units (ICUs) under immense pressure. This pressure has made ICUs more open to threats from superbugs. These are bacteria that are resistant to multiple drugs. One such superbug is carbapenem-resistant Acinetobacter baumannii. This bacteria is particularly

reading time less than a minute
Feb 20 2025SCIENCE

Bacteria's Fight Against Antibiotics: How CRISPR and MepA Work Together

Staphylococcus aureus, a common bacteria that can cause infections in both humans and animals, has been found to use a clever trick to resist antibiotics. Scientists looked at 234 samples of this bacteria from cows with mastitis. They found that only a small number, about 7. 69%, had a special defen

reading time less than a minute
Feb 09 2025HEALTH

An Engaging Quest to Make HS Diagnosis Timely

Hidden skin disease HS is more than just a skin issue. It has a strong impact on the life of the patients. The main problem is, doctors aren"t always familiar with it. This causes delays on patients getting the help they need. This new study hopes to change that. The study is called HELyx, happe

reading time less than a minute
Jan 01 2025SCIENCE

Fighting Superbugs: New Ways to Disrupt Drug Resistance

Imagine a world where antibiotics can't keep up with the bugs they're designed to fight. That's the challenge posed by carbapenemase-producing Enterobacterales (CPEs), a group of multidrug-resistant pathogens that are becoming increasingly hard to treat. These bacteria have plasmids, which are like

reading time less than a minute
Dec 19 2024HEALTH

Europe's Updated S2k Guidelines: A Fresh Take on Hidradenitis Suppurativa Treatments

Ever wondered how guidelines for treating skin conditions get updated? Well, Europe's latest S2k guidelines for hidradenitis suppurativa, also known as acne inversa, are out, and they're packed with new insights. This isn't just a revamp of the old 2015 S1 guidelines; it's a whole new ball game. Hi

reading time less than a minute
Dec 10 2024HEALTH

Hidradenitis Suppurativa and Psoriasis: Can Anti-IL-17/23 Drugs Help?

Hidradenitis suppurativa (HS) and psoriasis are both long-term inflammatory conditions that share similar immune system pathways. Both diseases involve cytokines like tumor necrosis factor-alpha, interleukin (IL)-17, and IL-23. Currently, treatment choices for HS are limited, with only adalimumab an

reading time less than a minute